Category Archives: Stem Cell Research

NEW ORLEANS Researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States, will present late-breaking and clinical trial findings at this years American Association for Cancer Research Annual Meeting, which begins today. These additional presentations showcase a pilot program in tobacco use cessation and new developments in cell therapy Continue reading →

The first patient with lymphoma received treatment with AB-205 in the phase 3 E-CELERATE trial assessing the novel cell therapy with high-dose chemotherapy and blood stem cell transplantation, according to a press release from Angiocrine Bioscience, the manufacturer of the therapy. AB-205 is a genetically engineered cell therapy that is administered intravenously and consists of allogeneic engineered human endothelial cells. It is currently being assessed in the E-CELERATE trial, in which researchers will evaluate the efficacy and safety of this cell therapy for the treatment of damaged organ vascular stem cell niches from high-dose chemotherapy. Continue reading →

The Persuasive India Cord Stem Cell Banking Market report is a total overview of the market that takes into account various aspects of product definition, market segmentation, and the existing merchant landscape. This industry report is comprehensive and encompasses a mixture of parameters of the market and India Cord Stem Cell Banking industry Continue reading →

DUBLIN--(BUSINESS WIRE)--The "Regenerative Medicine Market Research Report by Type, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering. The Global Regenerative Medicine Market size was estimated at USD 16.69 billion in 2021 and expected to reach USD 20.01 billion in 2022, and is projected to grow at a CAGR 20.03% to reach USD 49.94 billion by 2027 Continue reading →

Human respiratory system with close-up of alveoli and capillaries. Findings shine light on underpinnings of COPD, pave new direction for future research on treatments Continue reading →

Cases of successful treatment in Glioblastoma (GBM) offer hope that an enhanced understanding of the pathology will improve the prognosis. The cell of origin in GBM remains controversial Continue reading →

Bethany Almeida Bethany Almeida has been appointed assistant professor of chemical & biomolecular engineering at Clarkson University. She received her Ph.D. Continue reading →

Dublin, Aug. 24, 2021 (GLOBE NEWSWIRE) -- The "Circulating Tumor Cells Markets 2021-2027" report has been added to ResearchAndMarkets.com's offering Continue reading →

INTRODUCTION Given the consistent increase in number of cell therapies being developed and launched, this upcoming therapeutic segment is on its way to becoming one of the highest valued markets within the biopharmaceutical industry. New York, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cell Therapy Manufacturing Market by Type of Cell Manufactured, Source of Cell, Scale of Operation, Purpose of Manufacturing and Key Geographical Regions - Industry Trends and Global Forecasts, 2021-2030" - https://www.reportlinker.com/p06130492/?utm_source=GNW In fact, in February 2021, the USFDA approved Breyanzi, a CAR-T cell-based therapy, developed by Bristol Myers Squibb, which is designed to treat relapsed or refractory large B-cell lymphoma. Continue reading →

The University of California, Davis, set a new record for external research funding, receiving $968 million in awards in the fiscal year 2020-21, up $27 million from the previous record set last year. A major reason for this years growth was increased funding related to medicine and public health Continue reading →